Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
NCT06039046 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-09-15
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with liposarcoma who partake in a separate clinical research featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.
By joining this clinical study, individuals have the unique opportunity to contribute to the betterment of future liposarcoma patients and play an active role in advancing medical research.
Conditions
- Liposarcoma
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2025-10-31
- Completion
- 2026-10-31
Countries
- United States
Study Locations
More Related Trials
-
ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
NCT04132895 ·Status: RECRUITING
-
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
NCT00057616 ·Status: COMPLETED ·Phase: PHASE3
-
Cutaneous Squamous Cell Carcinoma Staging Study
NCT05695222 ·Status: RECRUITING
-
Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy
NCT05020912 ·Status: RECRUITING ·Phase: PHASE2
-
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
NCT01946217 ·Status: COMPLETED
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients
NCT04362722 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
NCT00055562 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Buddy Relationships in DermatoloGic Excisions for Skin Cancer
NCT04036344 ·Status: COMPLETED ·Phase: NA
-
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
NCT07228442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical Outcomes.
NCT06448936 ·Status: RECRUITING
-
Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
NCT06024226 ·Status: NOT_YET_RECRUITING
-
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
NCT06154668 ·Status: RECRUITING
-
Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma
NCT01455103 ·Status: WITHDRAWN ·Phase: PHASE1
-
Neoadjuvant L19IL2/L19TNF- Pivotal Study
NCT02938299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
NCT05907551 ·Status: UNKNOWN
-
Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
NCT06994208 ·Status: RECRUITING
-
A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study
NCT04805905 ·Status: UNKNOWN
-
Skin Care Behaviors Among Melanoma Survivors and Their Families
NCT02457065 ·Status: COMPLETED ·Phase: NA
-
Observational Study in Localized Osteosarcoma
NCT04890067 ·Status: RECRUITING
-
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
NCT00002860 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma
NCT07293598 ·Status: NOT_YET_RECRUITING
-
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
NCT06940739 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
L19IL2/TNF in Patients With Basal Cell Carcinoma
NCT07227870 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma
NCT03225365 ·Status: COMPLETED ·Phase: NA